NCT03400254 Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER") Status WITHDRAWN Phase PHASE1/PHASE2
NCT03399552 Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma Status COMPLETED Phase PHASE1/PHASE2
NCT03398473 A Study Comparing The Effects Of Epoetin Hospira Single-Dose Vial (SDV) And Multi-Dose Vial (MDV) When Administered Subcutaneously To Normal Healthy Subjects Status COMPLETED Phase PHASE1
NCT03395873 Avelumab With Decitabine as First Line for AML Treatment of Patients With AML, Who Are Unfit for Intensive Chemotherapy Status TERMINATED Phase PHASE1
NCT03395197 Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03395184 Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease Status COMPLETED Phase PHASE2
NCT03389477 Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03387423 Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT03386929 Survival Prolongation by Rationale Innovative Genomics Status TERMINATED Phase PHASE1/PHASE2
NCT03386279 A Study To Determine The Effect Of Single-dose PF-04965842 On QTc Interval In Healthy Volunteers Compared With Placebo and Moxifloxacin Status COMPLETED Phase PHASE1
NCT03375827 Feasibility of an Individualized Goals of Care Discussion Guide for Advanced Breast Cancer Status COMPLETED Phase NA
NCT03374332 Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03372044 A Study To Evaluate Different Formulations Of PF-06865571 In Healthy Subjects Status COMPLETED Phase PHASE1
NCT03362502 A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy Status TERMINATED Phase PHASE1
NCT03356977 A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis Status COMPLETED Phase PHASE4
NCT03356353 Sildenafil for the Prevention of Right Heart Failure Following LVAD Implantation Status UNKNOWN Phase PHASE3
NCT03355157 A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study). Status COMPLETED Phase PHASE4